Healthcare spending & insurance costs continue to skyrocket. Debate moderators can’t afford to let those vying for the nation’s highest office evade this critical issue.
Without a focused effort to clearly make the case for the true value of medicines and drug innovation, consumers’ negative perceptions about the industry will persist.
For the past two decades, the biopharma sector has witnessed the shedding of hundreds of thousands of jobs, and all signs point toward an acceleration of these losses.
Amazon has a long track record of disruption, and this latest move demonstrates that a more convenient, accessible, affordable, transparent healthcare model is possible.
Consumers are shouldering more of their healthcare costs and looking for alternatives. The last thing we need is a regulatory proposal that could leave many uninsured.
Given the size and revenue of these institutions it raises the question of what consolidation can achieve that such an already large system can’t achieve on its own.
There are no easy solutions to fix a broken healthcare system that’s expensive, inefficient and confusing to navigate, but government incompetence has only made it worse.